Manufacture

How can we best deliver solubility-challenged small molecules to the clinic?

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.

Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price.

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

Nominate the top pharmaceutical technologies in our 2020 Innovation Awards.

A typical vaccine takes around 10 to 12 years to reach the market. A key question: “Where should we base production?”

SCHOTT introduces an online shop with low minimum order quantities to overcome the challenges associated with conventional purchase order procedures.

Nominations are now open for The Medicine Maker 2021 Power List.